Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance

The status of platinum anticancer drugs in the clinic and in clinical trials

Nial Wheate, Shonagh Walker, Gemma E. Craig et al. · Dalton Transactions · 2010 · 1.6K citations

Medicine, Oncology, Pharmacology +15

Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery

Yao‐Rong Zheng, Kogularamanan Suntharalingam, Timothy C. Johnstone et al. · Journal of the American Chemical Society · 2014 · 435 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The Prodrug Platin‐<i>A</i>: Simultaneous Release of Cisplatin and Aspirin

Rakesh Pathak, Sean Marrache, Joshua H. Choi et al. · Angewandte Chemie International Edition · 2014 · 254 citations

Medicine, Oncology, Pharmacology +16

Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent

Simon Wisnovsky, Justin J. Wilson, Robert J. Radford et al. · Chemistry & Biology · 2013 · 187 citations

Medicine, Oncology, Pharmacology +9

Pt(<scp>iv</scp>) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action

Raji Raveendran, Jeremy Phillip Braude, Ezequiel Wexselblatt et al. · Chemical Science · 2016 · 180 citations · Full text

Medicine, Oncology, Pharmacology +8